The company
NovoCure Limited -
NVCR · Nasdaq
NVCR stood above a rising 150-day average in 21 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 9.1% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 3
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $6.5M
- Officials’ trades on record
- 3
- Institutions holding
- 205 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 21 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
3 disclosed lines: House 3, Senate 0, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Marie Newman House: U.S. House ClerkIL03 | boughtspouse | $15k–$50k | 2 Jul 2021filed 5 Aug 2021 |
| Donna E. Shalala House: U.S. House ClerkFL27 | sold | $1k–$15k | 24 Jun 2019filed 27 Apr 2020 |
| Donna E. Shalala House: U.S. House ClerkFL27 | bought | $1k–$15k | 19 Jun 2019filed 27 Apr 2020 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Frank X. LeonardChief Executive Officer | sold | 34,273at $17.93 | 4 Jun 2026filed 5 Jun 2026 |
| Jeryl L. HillemanDirector | sold | 2,945at $15.77 | 2 Jun 2026filed 3 Jun 2026 |
| Gabriel LeungDirector | sold | 2,945at $15.77 | 2 Jun 2026filed 3 Jun 2026 |
| David HungDirector | sold | 2,945at $15.77 | 2 Jun 2026filed 3 Jun 2026 |
| W. Anthony VernonDirector | sold | 2,945at $15.77 | 2 Jun 2026filed 3 Jun 2026 |
| Timothy J. ScannellDirector | sold | 2,945at $15.77 | 2 Jun 2026filed 3 Jun 2026 |
| Allyson J. OceanDirector | sold | 2,945at $15.77 | 2 Jun 2026filed 3 Jun 2026 |
| Kristin StaffordDirector | sold | 2,945at $15.77 | 2 Jun 2026filed 3 Jun 2026 |
| Mukund ParavasthuChief Operating Officer | sold | 43,246at $13.77 | 5 Mar 2026filed 5 Mar 2026 |
| Uri WeinbergChf Medical and Innovation Ofr | sold | 6,412at $13.31 | 4 Mar 2026filed 5 Mar 2026 |
| Frank X. LeonardChief Executive Officer | sold | 5,607at $13.31 | 4 Mar 2026filed 5 Mar 2026 |
| Michal Nath PuriChief Human Resources Officer | sold | 1,100at $13.31 | 4 Mar 2026filed 5 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCadded · filed 13 Aug 2026 | 17,373,078$263.2M | +303,929+1.8% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 13,413,699$203.2M | +219,934+1.7% |
| Soleus Capital Management, L.P.reduced · filed 11 Aug 2026 | 9,913,401$150.2M | -578,990−5.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 6,272,490$95.0M | +20,789+0.3% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 4,903,633$74.3M | +221,569+4.7% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 4,522,389$68.5M | -19,137−0.4% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 2,866,546$43.4M | +304,729+11.9% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 2,798,351$42.4M | +286,644+11.4% |
| WELLS FARGO & COMPANYreduced · filed 14 Aug 2026 | 2,528,093$38.3M | -423,144−14.3% |
| Quantinno Capital Management LPreduced · filed 13 Aug 2026 | 2,223,455$33.7M | -263,921−10.6% |
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.